Panayiotis G. Vlachoyiannopoulos

TL;DR: The use of biologic targeted therapies as an adjunct to disease-modifying antirheumatic drugs (DMARDs) for the treatment of autoimmune rheumatic diseases has completely changed standard of care and is still expanding.

TL;DR: The prevalence of antiphospholipid antibodies, particularly that of anti-beta2 glycoprotein-I and anti-phosphatidylserine antibodies, in women experiencing at least two implantation failures in IVF-ET without diagnosis of antIP syndrome is significantly greater than either in women who had a successful implantation after IVF -ET or women with at least one successful spontaneous pregnancy or unselected healthy fertile women with no history of IVf-ET.

TL;DR: AAb(+) patients with ILD seem to have a more favorable prognosis regarding all-cause mortality, long-term deterioration in lung function parameters and progression of HRCT findings than their AAb (-) counterparts.

TL;DR: Department of Pathophysiology, Medical School, National University of Athens, Greece.

TL;DR: In this first pedigree analysis of TRAPS in Greece, a wide clinical spectrum was observed with the C73Y, C73W and T50M mutations that affect TNFRSF1A disulphide bonds and are associated with worse symptoms.